CLASS III Drug recall · Reported 3 Dec 2014 · FDA Enforcement Report

Amlodipine Besylate Tablets, USP 10 mg recalled

Zydus Pharmaceuticals USA is recalling Amlodipine Besylate Tablets, USP 10 mg, distributed nationwide in the US. The recall was initiated on 1 Oct 2014 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: MP4344, Exp 04/2016
NDC68382-121, 68382-122, 68382-123
Quantity recalled15,144 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0257-2015
FDA event ID
69676
Recalling firm
Zydus Pharmaceuticals USA, Pennington, NJ
Manufacturer
Zydus Pharmaceuticals USA Inc.
Classification
Class III
Status
Terminated
Recall initiated
1 Oct 2014
FDA classified
21 Nov 2014
Reported
3 Dec 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

1 Oct 2014Recall initiated by company
21 Nov 2014Classified by FDA+51 days
3 Dec 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.

Product as listed by the FDA

Amlodipine Besylate Tablets, USP 10 mg, Rx Only, 90 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-123-16

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.

Which lots are affected?

Lot #: MP4344, Exp 04/2016

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Zydus Pharmaceuticals USA

All 41

Other Amlodipine recalls

All 81
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAmlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recalledAmlodipine And Olmesartan MedoxomilAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIAmlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg recalledAmlodipine And Olmesartan MedoxomilAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIAmlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg recalledAmlodipine And Olmesartan MedoxomilAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIAmlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg recalledAmlodipine Besylate And Benazepril HydrochlorideLupin PharmaceuticalsOtherNationwide
DrugCLASS IIIAmlodipine Besylate Tablets, USP 10 mg recalled by Lupin PharmaceuticalsAmlodipine BesylateLupin PharmaceuticalsPotency & AssayNationwide